Joram Mooiweer

Joram Mooiweer

Auto-generated profile, based on publicly available information

Joram Mooiweer

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2018 in OncoImmunology
Verified
Journal Article
Open access
IAIsabell Adam
Isabell Adam
DDDyah L. Dewi
Dyah L. Dewi
JMJoram Mooiweer
Joram Mooiweer
ASAhmed Sadik
Ahmed Sadik
SMSoumya R. Mohapatra
Soumya R. Mohapatra
COChristiane A. Opitz
Christiane A. Opitz
Tryptophan (Trp) metabolism is an important target in immuno-oncology as it represents a powerful immunosuppressive mechanism hijacked by tumors for protection against immune destruction. However, it remains unclear how tumor cells can proliferate while degrading the essential amino acid Trp. Trp is incorporated into proteins after it is attached to its tRNA by tryptophanyl-tRNA synthestases. As the tryptophanyl-tRNA synthestases compete for Trp with the Trp-catabolizing enzymes, the balance between these enzymes will determine whether Trp is used for protein synthesis or is degraded. In human cancers expression of the Trp-degrading enzymes indoleamine-2,3-dioxygenase-1 (IDO1) and tryptophan-2,3-dioxygenase (TDO2) was positively associated with the expression of the tryptophanyl-tRNA synthestase WARS. One mechanism underlying the association between IDO1 and WARS identified in this study is their joint induction by IFNγ released from tumor-infiltrating T cells. Moreover, we show here that IDO1- and TDO2-mediated Trp deprivation upregulates WARS expression by activating the general control non-derepressible-2 (GCN2) kinase, leading to phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α) and induction of activating transcription factor 4 (ATF4). Trp deprivation induced cytoplasmic WARS expression but did not increase nuclear or extracellular WARS levels. GCN2 protected the cells against the effects of Trp starvation and enabled them to quickly make use of Trp for proliferation once it was replenished. Computational modeling of Trp metabolism revealed that Trp deficiency shifted Trp flux towards WARS and protein synthesis. Our data therefore suggest that the upregulation of WARS via IFNγ and/or GCN2-peIF2α-ATF4 signaling protects Trp-degrading cancer cells from excessive intracellular Trp depletion.

26 August 2024 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
DNDennis M. Nahon
Dennis M. Nahon
RMRenée Moerkens
Renée Moerkens
HAHande Aydogmus
Hande Aydogmus
BLBas Lendemeijer
Bas Lendemeijer
AMAdriana Martínez-Silgado
Adriana Martínez-Silgado
CMChristine L. Mummery
Christine L. Mummery

7 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJoram Mooiweer
Joram Mooiweer
Sajid AnwarSajid Anwar
Sajid Anwar
NRNathan Vinícius Ribeiro
Nathan Vinícius Ribeiro
ARAarón D. Ramírez-Sánchez
Aarón D. Ramírez-Sánchez
HSHanna Simpson
Hanna Simpson
IJIris H Jonkers
Iris H Jonkers
Interactions between intraepithelial lymphocytes (IELs) and the intestinal epithelium are central to mucosal homeostasis and disease. However, mechanistic in vitro studies describing their crosstalk in humans are limited by scarceness of primary material and insufficient knowledge about co-culture requirements. Here, we establish an autologous human duodenal IEL–organoid co-culture system encompassing expandable and bankable IEL and organoid protocols, with co-culture conditions that allow viability of both cell types. This system enables successive interrogation of lympho-epithelial interactions starting from minimal biopsy material. Under baseline conditions, CD45⁺CD8⁺CD103⁺TCRαβ⁺ IELs retain tissue-residency and effector features and induce an epithelial interferon response and chemokine production, without overt epithelial apoptosis. IL-15 and IL-21, essential cytokines involved in IEL-activation in intestinal enteropathies like celiac disease, increases granzyme B expression and interferon-γ secretion but do not trigger epithelial cell death. However, enforcing IEL-epithelial contact using an anti-CD3-anti-Ep-CAM bispecific antibody induces epithelial apoptosis accompanied by increased tumor necrosis factor (TNF) and FAS-ligand (FASLG) secretion. These findings validate the platform’s ability to resolve non-destructive and cytotoxic lympho-epithelial interaction and provide a tractable system for studying intestinal inflammation and immune-mediated epithelial cell death.